INAUGURAL POST
Nonpartisan pharma news and views from the horse’s mouth, not the jockey’s
WE NEED TO KNOW THIS WILL GET PROPER REGULATORY SCRUTINY
Hot on the heels of the Pfizer/BioNTech SARS-CoV-2 injection comes the next candidates for mRNA treatment – Shingles.
In an article published in PHARMACEUTICAL TECHNOLOGY, titled Pfizer and BioNTech enter deal to develop first mRNA vaccine for shingles, January 6, 2022, the deal was described by Pfi…